Advertisement

Topics

FDA approves Alembic's drug for bacterial infections

05:17 EDT 1 Aug 2017 | SmartBrief

The FDA has granted approval to Alembic Pharmaceuticals' Doxycycline capsules USP in 75 mg and 100 mg as a treatment for bact -More

Original Article: FDA approves Alembic's drug for bacterial infections

NEXT ARTICLE

More From BioPortfolio on "FDA approves Alembic's drug for bacterial infections"

Quick Search
Advertisement